Small Subgroups May Hold Big Clinical Clues in Oncology

Maurie Markman, MD
Published: Monday, Sep 23, 2019
Maurie Markman, MD

Maurie Markman, MD
Phase III randomized trials have played a critical role in the development of modern cancer therapeutics. It would be difficult to imagine what cancer care would look like today in the absence of well-designed, appropriately conducted, ultimately reported, and solidly evidence-based clinical studies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication